Foundery Launches Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies
22 août 2023 07h30 HE
|
Foundery Innovations
SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, today announced an initial closing of...
Foundery and the University of Arizona Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies
06 avr. 2023 08h00 HE
|
Foundery Innovations
SAN FRANCISCO, April 06, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, has entered into a master agreement...
Foundery Innovations Establishes Scientific Advisory Board with Appointment of Key Opinion Leaders in Immunology and Oncology
28 mars 2023 08h00 HE
|
Foundery Innovations
SAN FRANCISCO, March 28, 2023 (GLOBE NEWSWIRE) -- Foundery Innovations (“Foundery”), a biotechnology venture studio focused on translating immunology discoveries into drug candidates, announced the...
Foundery Innovations Adds to Executive and Scientific Teams with Two Key Appointments
01 mars 2023 08h00 HE
|
Foundery Innovations
Jate Samathivathanachai, MBA, CLP, as Chief Business OfficerVladi Juric, Ph.D., as Senior Director and Head of Pharmacology SAN FRANCISCO, March 01, 2023 (GLOBE NEWSWIRE) -- Foundery Innovations...
The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies
09 févr. 2023 08h00 HE
|
Foundery Innovations
SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The University of California, San Francisco (“UCSF”) and Foundery, a biotechnology venture studio focused on translating immunology discoveries into...